Bioengineered nanovesicles could improve cancer treatment

Nanovesicles can be bioengineered to target cancer cells and deliver treatments directly, according to research at Binghamton University, State University of New York.

Updated recommendations for management of people with hip and knee osteoarthritis

OA affects over 500 million people worldwide. The disease is age related, and usually starts to affect people in middle age.

January 29, 2024

Former Schrödinger exec launches RA Capital-backed startup for AI drug discovery

Superluminal Medicines, a startup claiming that it can use artificial intelligence to shrink the development of preclinical drug candidates from years to a matter of

August 29, 2023

Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 – Biotech Investments

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.